Ani Pharmaceuticals, Inc. <ANIP.O>: Leerink Partners assumes coverage with outperform rating; price target $104
ANIP•Related News
Docebo’s Intercap stake slips to 63.7% after issuer bid buyback
DCBO•
Deckers Brands: BMO initiates coverage with underperform rating; target price $70
DECK•
Pet products retailer Chewy's Q2 revenue edges past estimates on recurring sales strength
CHWY•
Adobe Inc <ADBE.O>: Stifel Raises Target Price to $225 From $200
ADBE•
Oil prices fly blind as the Hormuz enigma deepens: Bousso
XLE•